Clinical trial
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
NCT02400944 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determinants of Bladder Cancer Recurrence Study (The DETER Study)
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 31, 2015
- Completion date
- March 31, 2027
- Enrollment
- 600 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer